CS logo
small CS logo
Queen Elizabeth Hospital; Clinical Oncology

Hong Kong, Hong Kong
Hospital department in Hong Kong
30號 Gascoigne Rd, Yau Ma Tei

About Queen Elizabeth Hospital; Clinical Oncology


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
11
Hong Kong Nasopharyngeal Cancer Study Group Limited
1
Pfizer
1
The Hong Kong Polytechnic University
1
Total Rows: 4

Clinical Trials at Queen Elizabeth Hospital; Clinical Oncology


During the past decade, Queen Elizabeth Hospital; Clinical Oncology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 7 clinical trials were completed, i.e. on average, 140% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years111111110011111122220011Started TrialsCompleted Trails2015201620172018201920200123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma
2006-09-01
2018-12-01
Completed
803
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
2007-07-01
2014-09-01
Completed
223
A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma
2007-07-26
2011-11-30
Terminated
787
A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)
2010-01-26
2017-08-07
Completed
452
A Study of Tarceva (Erlotinib) as First Line Therapy in Participants With Non-Small Cell Lung Cancer Harbouring Epidermal Growth Factor Receptor (EGFR) Mutations
2011-04-30
2016-12-30
Completed
208
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2012-05-17
2020-02-19
Completed
2,577
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
2012-06-01
2019-09-20
Completed
1,436
A Study of Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2014-01-22
2019-01-11
Completed
667

Rows per page:

1–14 of 14

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Elizabeth Hospital; Clinical Oncology" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 11Hoffmann-La Roche: 11Hong KongNasopharyngeal CancerStudy Group Limited: 1Hong KongNasopharyngeal CancerStudy Group Limited: 1Pfizer: 1Pfizer: 1The Hong KongPolytechnic University:1The Hong KongPolytechnic University:1

Created with Highcharts 11.1.0Top CollaboratorsAlliance FoundationTrials (AFT): 1Alliance FoundationTrials (AFT): 1Breast International Group: 1Breast International Group: 1Frontier Science &Technology ResearchFoundation, Inc.: 1Frontier Science &Technology ResearchFoundation, Inc.: 1Genentech, Inc.: 1Genentech, Inc.: 1Institut JulesBordet/Clinical TrialsSupport Unit (IJB/CTSU):1Institut JulesBordet/Clinical TrialsSupport Unit (IJB/CTSU):1The Hong Kong Anti-Cancer Society: 1The Hong Kong Anti-Cancer Society: 1hong Kong Cancer Fund: 1hong Kong Cancer Fund: 1

Clinical Trials Conditions at Queen Elizabeth Hospital; Clinical Oncology


According to Clinical.Site data, the most researched conditions in "Queen Elizabeth Hospital; Clinical Oncology" are "Breast Neoplasms" (3 trials), "Non-Small Cell Lung Cancer" (2 trials), "Advanced Breast Cancer" (1 trials), "Advanced Gastric Cancer" (1 trials) and "Advanced/Metastatic Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Queen Elizabeth Hospital; Clinical Oncology" in a lesser frequency.

Clinical Trials Intervention Types at Queen Elizabeth Hospital; Clinical Oncology


Most popular intervention types in "Queen Elizabeth Hospital; Clinical Oncology" are "Drug" (13 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (4 trials), "Alectinib" (2 trials), "Capecitabine" (2 trials), "Docetaxel" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Queen Elizabeth Hospital; Clinical Oncology


The vast majority of trials in "Queen Elizabeth Hospital; Clinical Oncology" are 13 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Queen Elizabeth Hospital; Clinical Oncology


Currently, there are NaN active trials in "Queen Elizabeth Hospital; Clinical Oncology". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Queen Elizabeth Hospital; Clinical Oncology, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Queen Elizabeth Hospital; Clinical Oncology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 10Phase 3: 10Not Applicable: 2Not Applicable: 2Phase 2: 2Phase 2: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 9Completed: 9Active, not recruiting: 3Active, not recruiting: 3Recruiting: 1Recruiting: 1Terminated: 1Terminated: 1